FR2527211A1 - Nouveaux sels de theophylline 8-substituee utiles comme reactifs dans un dosage immunologique avec inhibiteur enzymatique competitif irreversible - Google Patents

Nouveaux sels de theophylline 8-substituee utiles comme reactifs dans un dosage immunologique avec inhibiteur enzymatique competitif irreversible Download PDF

Info

Publication number
FR2527211A1
FR2527211A1 FR8308412A FR8308412A FR2527211A1 FR 2527211 A1 FR2527211 A1 FR 2527211A1 FR 8308412 A FR8308412 A FR 8308412A FR 8308412 A FR8308412 A FR 8308412A FR 2527211 A1 FR2527211 A1 FR 2527211A1
Authority
FR
France
Prior art keywords
reagents
irreversible
enzyme
inhibitor
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8308412A
Other languages
English (en)
French (fr)
Other versions
FR2527211B1 (enExample
Inventor
Curtis Lee Kirkemo
Charles Arthur Flentge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2527211A1 publication Critical patent/FR2527211A1/fr
Application granted granted Critical
Publication of FR2527211B1 publication Critical patent/FR2527211B1/fr
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
FR8308412A 1982-05-24 1983-05-20 Nouveaux sels de theophylline 8-substituee utiles comme reactifs dans un dosage immunologique avec inhibiteur enzymatique competitif irreversible Granted FR2527211A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/380,981 US4451652A (en) 1982-05-24 1982-05-24 Substituted theophylline salts

Publications (2)

Publication Number Publication Date
FR2527211A1 true FR2527211A1 (fr) 1983-11-25
FR2527211B1 FR2527211B1 (enExample) 1985-05-17

Family

ID=23503202

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8308412A Granted FR2527211A1 (fr) 1982-05-24 1983-05-20 Nouveaux sels de theophylline 8-substituee utiles comme reactifs dans un dosage immunologique avec inhibiteur enzymatique competitif irreversible

Country Status (9)

Country Link
US (1) US4451652A (enExample)
JP (1) JPS58213791A (enExample)
BE (1) BE896802A (enExample)
CA (1) CA1215051A (enExample)
DE (1) DE3318809C2 (enExample)
ES (1) ES522679A0 (enExample)
FR (1) FR2527211A1 (enExample)
GB (1) GB2121803B (enExample)
IT (1) IT1164234B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543412A (en) * 1983-11-04 1985-09-24 Abbott Laboratories Phenobarbital enzyme inhibitors
CA2341263C (en) * 1999-06-25 2006-08-01 Roche Diagnostics Corporation Enzyme inhibition immunoassay
US6962209B2 (en) * 2001-10-17 2005-11-08 Turfco Manufacturing Inc. Simple, durable and easy-to-use earthworking machine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273866A (en) * 1979-02-05 1981-06-16 Abbott Laboratories Ligand analog-irreversible enzyme inhibitor conjugates and methods for use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273866A (en) * 1979-02-05 1981-06-16 Abbott Laboratories Ligand analog-irreversible enzyme inhibitor conjugates and methods for use

Also Published As

Publication number Publication date
FR2527211B1 (enExample) 1985-05-17
GB2121803A (en) 1984-01-04
IT1164234B (it) 1987-04-08
CA1215051A (en) 1986-12-09
ES8406480A1 (es) 1984-08-01
DE3318809C2 (de) 1985-01-03
IT8321257A0 (it) 1983-05-24
DE3318809A1 (de) 1983-11-24
GB2121803B (en) 1985-10-23
BE896802A (fr) 1983-11-21
IT8321257A1 (it) 1984-11-24
JPS58213791A (ja) 1983-12-12
US4451652A (en) 1984-05-29
JPH0134228B2 (enExample) 1989-07-18
ES522679A0 (es) 1984-08-01
GB8311847D0 (en) 1983-06-02

Similar Documents

Publication Publication Date Title
US5807847A (en) Nitrate esters
US5198537A (en) Digoxigenin derivatives and use thereof
Levine et al. Oxidation of dihydronicotinamides by flavopapain
Landt et al. Alkaline phosphatase: affinity chromatography and inhibition by phosphonic acids
EP0243429A1 (de) D-luciferin-derivate und deren verwendung.
Zhang et al. Purification of a nitric oxide-stimulated ADP-ribosylated protein using biotinylated. beta.-nicotinamide adenine dinucleotide
EP0216553A2 (en) Acridine ester and acridinium ester synthesis
JPH04503059A (ja) 5′―ビオチン化オリゴヌクレオチド製造用の試剤
CA1220148A (en) 9-(aminoalkyl)-8-hydroxyadenines and method of their preparation
US5171679A (en) Cyanocobalamin acid hydrazides and their conjugates
FR2527211A1 (fr) Nouveaux sels de theophylline 8-substituee utiles comme reactifs dans un dosage immunologique avec inhibiteur enzymatique competitif irreversible
EP0205005B1 (en) New biologically active fluorescent cyclic nucleotides
JPS59160762A (ja) 甲状腺ホルモン3,3′,5−トリヨ−ドチロニン(t↓3)および3,3′,5,5′−テトラヨ−ドチロニン(t↓4)の不溶の誘導体の製法
Spande Synthesis of two novel phosphorylcholine esters for probes in immunological studies
US4188320A (en) Ester of higher fatty acid and reagent for determination of activity of lipase
IL131177A0 (en) Process for the preparation of nicotinic acids
Gunshore et al. Inhibition of the catalytic subunit of phosphorylase phosphatase by oxalyl thioesters and its possible relevance to the mechanism of insulin action
FR2674248A1 (fr) Procede de modification chimique des proteines.
RIEKE et al. N6‐[N‐(6‐Aminohexyl) carbamoylmethyl]‐coenzyme A: Synthesis and Application in Affinity Chromatography and as an Immobilized Active Coenzyme
Ridgewell et al. Stereochemical aspects of the glutathione S-transferase-catalyzed conjugations of alkyl halides.
US5808092A (en) Process for preparing-1-ethyl-5-hydroxypyrazole
JPH0615480B2 (ja) アシル化剤
US4179568A (en) (N-lower alkyl-3,5-dioxo-3-pyrrolidinyl)thioalkanoylpyrrolidine-and piperidine-carboxylic acid compounds
EP0216162A2 (en) A method of preparing indoles or indole derivatives, coupled via position 4, 5, 6, or 7, the indoles or indole derivatives concerned, as well as the use thereof
SE8205563D0 (sv) Process for the preparation of vincaminic acid esters

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse